Holdings
Portfolio Building Block World Pharma and Biotech Index ETF
As of Jul 31, 2026, Portfolio Building Block World Pharma and Biotech Index ETF reported 52 positions worth US$902M. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 126K | US$145M | first report | Jul 31, 2026 |
| Johnson & Johnson | 359K | US$92M | first report | Jul 31, 2026 |
| Abbvie Inc. | 264K | US$66.1M | first report | Jul 31, 2026 |
| Merck & Company, Inc. | 368K | US$48M | first report | Jul 31, 2026 |
| Amgen Inc. | 115K | US$44.1M | first report | Jul 31, 2026 |
| Novartis Ag | 272K | US$42.6M | first report | Jul 31, 2026 |
| Astrazeneca Plc | 218K | US$37.1M | first report | Jul 31, 2026 |
| Gilead Sciences, Inc. | 276K | US$35.9M | first report | Jul 31, 2026 |
| Novo Nordisk A/s Class B | 708K | US$33.4M | first report | Jul 31, 2026 |
| Pfizer, Inc. | 1.27M | US$31.7M | first report | Jul 31, 2026 |